NCT07162428

Brief Summary

The aim of this study is to examine the effect of art therapy applied to inpatients in the psychiatry ward on disease severity and anxiety levels. Art therapy is considered a complementary intervention that can positively contribute to the psychiatric recovery process by facilitating the expression and regulation of an individual's emotional state. This research will be conducted with a randomized controlled design and aims to demonstrate the effectiveness of art therapy practices within the clinical process through objective data. The originality of the study lies in the fact that art therapy will be implemented with individuals hospitalized in an acute psychiatric ward. In this respect, the study provides the opportunity to evaluate the applicability of art therapy even during crisis periods and carries the potential to make significant practice-oriented contributions to the field of mental health.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 9, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

September 23, 2025

Status Verified

August 1, 2025

Enrollment Period

1 day

First QC Date

August 31, 2025

Last Update Submit

September 17, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Young Mania Rating Scale (YMRS)

    The YMRS is an 11-item scale developed by Young et al. to assess the severity of manic episodes. Seven items are rated on a 5-point Likert scale and four items on a 9-point Likert scale, with a total score range of 0 to 44. The Turkish version has been validated for reliability and validity. The total score can range from 0 to 60, with higher scores indicating more severe manic symptoms.

    Before and after each therapy session (daily assessments during the 5-day intervention week for each group). Each group receives one week of therapy; in total, three groups will complete the intervention over three consecutive weeks.

  • State-Trait Anxiety Inventory (STAI - Form I and II)

    Self-report measure assessing state and trait anxiety, consisting of 20 items each, rated on a 4-point Likert scale.

    Before and after each session across the 5-day intervention week for each group (three groups in total, over three weeks).

  • Positive and Negative Syndrome Scale (PANSS)

    The PANSS is a 30-item scale developed by Kay et al. to assess positive symptoms, negative symptoms, and general psychopathology in schizophrenia. Scores are rated across three subscales. The Turkish version has been validated by Kostakoğlu et al. In this scale (PANSS: Positive and Negative Syndrome Scale), as the score increases, symptoms/psychopathology become more severe. In other words, the higher the score, the greater the severity of symptoms and the greater the impairment in the patient's daily functioning.

    Before and after each session across the 5-day intervention week for each group (three groups in total, over three weeks).

Study Arms (2)

Art Therapy Intervention

EXPERIMENTAL

Participants in this group will receive art therapy sessions in addition to standard psychiatric care. The intervention will consist of 3 sessions per week, conducted on 5 consecutive days, with each session lasting approximately 50 minutes. Sessions will be carried out in groups of 8 participants and will focus on creative expression through drawing and painting. All sessions will be facilitated by a trained art therapist.

Behavioral: Art Therapy

Control Group (Standard Care)

NO INTERVENTION

Participants in this group will receive standard psychiatric care without additional art therapy sessions.

Interventions

Art TherapyBEHAVIORAL

The art therapy sessions will be conducted by a certified art therapist who has completed a two-year training program, together with a psychiatric nurse who has completed a 4-hour training course on "Severe Personality Disorders and Therapeutic Interventions - Art Therapy." A clinical nurse and a psychiatry resident will also participate as observers. The therapist will deliver the intervention through semi-structured sessions, following a predefined content and method. These sessions are referred to as Semi-Structured Art Therapy Sessions.

Art Therapy Intervention

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older.
  • Currently hospitalized in the psychiatry clinic and expected to remain hospitalized during the study period.
  • No medical condition such as intellectual disability or organic mental disorder that would interfere with the administration of scales and tests.
  • A PANSS score of ≤62 (since a score of 61 is considered the remission criterion in schizophrenia, patients scoring 62 or below will be included).
  • A score between 5-18 on the Young Mania Rating Scale.
  • Receiving treatment in the clinic for at least 3 days.
  • Providing verbal and/or written informed consent to participate in the study.

You may not qualify if:

  • Being in an acute psychotic episode or having severe psychotic symptoms (e.g., severe delusions, hallucinations) making the patient unsuitable for group participation.
  • Clinical conditions involving excessive agitation or homicidal risk that make group participation inappropriate.
  • Inability to actively participate in art therapy due to visual, hearing, or severe motor impairments.
  • Patients for whom discharge is planned during the clinical course (e.g., those scheduled for discharge in less than 3 days).
  • Diagnosis of an organic mental disorder (e.g., dementia, delirium).
  • Severe physical illness or motor impairment preventing participation in group activities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Mental Disorders

Interventions

Art Therapy

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Tuğba ŞAHİN TOKATLIOĞLU, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study; neither participants nor investigators are blinded to the intervention.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either the art therapy intervention group or the control group receiving standard care
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2025

First Posted

September 9, 2025

Study Start

September 15, 2025

Primary Completion

September 16, 2025

Study Completion

November 1, 2025

Last Updated

September 23, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share